Revisiting the safety profile: Understanding the link between Methotrexate and skin cancer in psoriasis patients

J Pak Med Assoc. 2023 Dec;73(12):2537. doi: 10.47391/JPMA.10052.
No abstract available

MeSH terms

  • Dermatologic Agents* / adverse effects
  • Humans
  • Immunosuppressive Agents
  • Methotrexate / adverse effects
  • Psoriasis* / drug therapy
  • Skin Neoplasms* / epidemiology

Substances

  • Methotrexate
  • Immunosuppressive Agents
  • Dermatologic Agents